Commonwealth Coat of Arms of Australia

 

PB 58 of 2025

 

National Health (Highly Specialised Drugs Program) Special Arrangement Amendment (June Update) Instrument 2025

 

National Health Act 1953

 

I, REBECCA RICHARDSON, Assistant Secretary, Pricing and PBS Policy Branch, Technology Assessment and Access Division, Department of Health, Disability and Ageing, delegate of the Minister for Health and Ageing, make this Instrument under subsection 100(2) of the National Health Act 1953.

Dated 29 May 2025

REBECCA RICHARDSON

Assistant Secretary

Pricing and PBS Policy Branch

Technology Assessment and Access Division

 

 

1 Name

2 Commencement

3 Authority

4 Schedules

Schedule 1—Amendments

National Health (Highly Specialised Drugs Program) Special Arrangement 2021
(PB 27 of 2021) 2

 

  1.            This instrument is the National Health (Highly Specialised Drugs Program) Special Arrangement Amendment (June Update) Instrument 2025.
  2.            This instrument may also be cited as PB 58 of 2025.
  1.            Each provision of this instrument specified in column 1 of the table commences, or is taken to have commenced, in accordance with column 2 of the table. Any other statement in column 2 has effect according to its terms.

 

Commencement information

Column 1

Column 2

Column 3

Provisions

Commencement

Date/Details

1. The whole of this instrument

1 June 2025

1 June 2025

Note: This table relates only to the provisions of this instrument as originally made. It will not be amended to deal with any later amendments of this instrument.

  1.            Any information in column 3 of the table is not part of this instrument. Information may be inserted in this column, or information in it may be edited, in any published version of this instrument.

 This instrument is made under subsection 100(2) of the National Health Act 1953.

 Each instrument that is specified in a Schedule to this instrument is amended or repealed as set out in the applicable items in the Schedule concerned, and any other item in a Schedule to this instrument has effect according to its terms.

 

 

 

 

 

 

Adalicip

C12120 C14061 C14063 C14064 C14107 C14136

 

See Schedule 2

See Schedule 2

 

 

 

AzacitidineTeva

C12439 C12983 C12986 C13010 C13011 C13012 C13015 C13029

 

See Schedule 2

See Schedule 2

 

 

 

Cyclosporin Sandoz

C6631 C6638 C6643 C6660 C9694 C9695 C9742 C9764 C15360 C15361

 

120

5